Dsm-Firmich has Completed the Closure of Two Vitamin Factories in China

On February 29, DSM-Firmich released its 2023 comprehensive annual report. Management pointed out in an open letter to shareholders that the company had previously launched a vitamin transformation plan and accelerated the implementation of post-merger cost synergy plans. By the end of last year, significant progress had been made in the execution of the above plans through the closure of China’s Xinghuo vitamin B6 factory and the closure of China’s Jiangshan vitamin C factory. Management said it is on track to achieve its annual synergy target of approximately 350 million euros in adjusted earnings before interest, taxes, depreciation and amortization (EBITDA), about half of which is expected to come from cost efficiencies. (Source: Foodaily)

Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE

Visit HPA-China’s Information Hub, HERE